80jili login

Co-founder and current CEO Scott Knoll to transition to Executive Chairman NEW YORK , Dec. 9, 2024 /PRNewswire/ -- Guideline.ai , a leading provider of advertising data and planning technology, announced that Vincent Mifsud will become its new Chief Executive Officer, succeeding the company's co-founder, Scott Knoll , who will now serve as Executive Chairman. Mifsud brings decades of experience building high-performing teams and impactful technology products. Most recently, Mr. Mifsud was the Global President of Enghouse Systems Limited, a leading global B2B enterprise software company with a suite of vertically focused software products. The company grew significantly during his time at Enghouse, expanding to approximately 1,800 employees and over $350 million in revenue. Prior to joining Enghouse, he was CEO of Scribble Technologies, a leading content marketing SaaS provider, and held executive roles with high-growth companies such as Genesis, Pivotal and Rand Technologies. Mifsud's track record improving customer outcomes through technology and process improvement, along with his experience serving marketers, makes him a perfect fit to join the Guideline team for the next step of its accelerated growth journey. " Scott Knoll's founding vision for Guideline is more relevant now than ever," said Vince Mifsud . "I look forward to working with him and the talented team at Guideline to build on an exciting foundation of the world's most comprehensive and accurate media investment data and the leading media planning application used by the majority of top global advertisers." Knoll founded Guideline in 2020 to improve the media investment ecosystem through new applications of data science. This thesis led to Guideline's acquisitions of Standard Media Index and SQAD in 2022, and Lumina in 2023. Following the acquisitions, Guideline has introduced exciting innovations into the marketplace, including new insights into programmatic media investment activity and a next-generation ad planning software platform. In his role as Executive Chairman, Knoll will continue to drive the Company's integrated product vision and support its customer relationships. "Vince brings a wealth of experience helping businesses achieve their potential and is deeply aligned with our company's vision, values, and growth strategy," said Knoll. "I look forward to working with Vince in support of our customers and partners as we continue to build innovative new products and solutions for the advertising ecosystem." About Guideline Guideline, a leading provider of advertising data and planning technology, has become the world's most trusted authority on media investment and intelligence. The company was formed through the acquisitions of Standard Media Index, SQAD, and Lumina. With its market-leading media planning platform, industry-best ad market data and unrivaled customer service, Guideline effectively meets the evolving needs of today's marketing, media and investment professionals. To learn more about Guideline, visit guideline.ai or follow us on LinkedIn. View original content to download multimedia: https://www.prnewswire.com/news-releases/guideline-announces-vincent-mifsud-as-ceo-302326355.html SOURCE GuidelineHochul asks Biden admin. for more border resources

5 Of The Best Non-Samsung Android Phones You Can BuyNo, Robert F. Kennedy Jr. has not announced plans to ban Hershey's chocolateU.S. Compounding Pharmacies Market Set for Exceptional Growth in the Forecast 2024-2032 12-27-2024 07:07 PM CET | Health & Medicine Press release from: Cognate Insights U.S. Compounding Pharmacies Market Latest Market Overview The U.S. compounding pharmacies market is expected to grow significantly, with a projected market size of USD 11.5 billion in 2024 and a compound annual growth rate (CAGR) of 7.2% from 2024 to 2032. Compounding pharmacies, which specialize in preparing personalized medications tailored to individual patient needs, are playing an increasingly vital role in the healthcare sector. This growth is driven by the increasing prevalence of chronic diseases, a shift toward personalized medicine, and the rising demand for custom medications that cannot be met by commercially available drug products. Compounding pharmacies offer specialized formulations, such as hormone replacement therapy (HRT), pediatric medications, pain management solutions, and dermatological creams, contributing to their market expansion. The U.S. Compounding Pharmacies Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the U.S. Compounding Pharmacies industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of U.S. Compounding Pharmacies Market are: Fagron, Inc. (Headquarters: Michigan, USA) - Revenue: USD 500 million (2023) PharMEDium Services, LLC (Headquarters: Illinois, USA) - Revenue: USD 450 million (2023) Custom Medication Services (Headquarters: Texas, USA) - Revenue: USD 230 million (2023) Maverick Compounding Pharmacy (Headquarters: California, USA) - Revenue: USD 150 million (2023) Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/us-compounding-pharmacies-market-research Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global U.S. Compounding Pharmacies Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/us-compounding-pharmacies-market-research Key drivers and challenges influencing the U.S. Compounding Pharmacies market: Regional Analysis: The report involves examining the U.S. Compounding Pharmacies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the U.S. Compounding Pharmacies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual U.S. Compounding Pharmacies manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards U.S. Compounding Pharmacies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to U.S. Compounding Pharmacies. It assesses the current state, advancements, and potential future developments in U.S. Compounding Pharmacies areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the U.S. Compounding Pharmacies market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/us-compounding-pharmacies-market-research Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.

Thomas scores 27 as Morgan State downs Campbell 86-76Google CEO Pichai tells employees to gear up for big 2025: ‘The stakes are high'Arizona junior offensive lineman Jonah Savaiinaea is heading for the NFL. Savaiinaea officially declared for the NFL Draft on Sunday and will forego his senior season, he announced on his social media accounts. Savaiinaea is a projected first- or second-round pick. Savaiinaea is projected by ESPN to land at No. 31 overall to the Detroit Lions. ESPN draft analyst Matt Miller said Savaiinaea is "a mauler in the run game and has shown improved footwork and poise in pass-blocking." Miller also projects wide receiver Tetairoa McMillan as the first Wildcat taken at eighth overall by the Carolina Panthers. It's conceivable Arizona has two first-round picks in the same draft since linebacker Chris Singleton (New England Patriots) and defensive end Anthony Smith (Oakland Raiders) in 1990. In his farewell post on Instagram, Savaiinaea thanked Jedd Fisch and Brent Brennan, his two coaches at the UA, along with offensive line coaches Brennan Carroll and Josh Oglesby and his family and teammates. "Finally, to the Wildcat family, thank you all for welcoming me here in Tucson," Savaiinaea said. "It has been an unforgettable experience the past three years. Thank you for the never-ending support and love." Arizona offensive lineman Jonah Savaiinaea (71) awaits the snap of the football during the Wildcats’ win over Utah on Sept. 28 in Salt Lake City, Utah. The 6-5, 336-pound Savaiinaea, a Tafuna, American Samoa native, switched positions thrice since becoming a Wildcat. After signing with Arizona in 2022 following a standout career at St. Louis High School in Honolulu, Savaiinaea played 2,418 snaps — including 1,057 at right tackle, 985 at right guard and 345 at left tackle. Savaiinaea took over the reins at left tackle once redshirt freshman Rhino Tapa'atoutai suffered a season-ending leg injury, but missed the season finale against Arizona State due to a leg he injury he suffered against TCU. “He’s so special,” Arizona quarterback Noah Fifita said of Savaiinaea. “That’s been the case since he got on campus. He started as a true freshman at guard, moved to right tackle last year and then obviously moved to left tackle when Rhino went down. His versatility, his swagger, his confidence — he’s never afraid to do what he needs to do for the team. “Him being an offensive lineman, he doesn’t get as much attention as he should, but at the end of the day, he’s a first-round draft pick. That’s been that way since he arrived campus. It’s a blessing having him protect us.” Savaiinaea was Arizona's most durable, plug-and-play offensive lineman in the last three years. Savaiinaea allowed eight sacks and five quarterback hits in three years, according to Pro Football Focus. "That speaks to what kind of teammate he is (and) how much he cares about Arizona football," said Brennan. "His willingness to move from right tackle to left tackle, then back to right and back to left. That speaks so much about how much he cares about his team, how much he cares about his teammates and how much he cares about the U of A." Savaiinaea is “an awesome football player and an even better person,” Brennan said. “Anyone who knows big Jonah know he has a huge heart, definitely a hard worker, crazy competitor and it’s so important to him," he added. "I’m excited for the next chapter for him.” Contact Justin Spears, the Star's Arizona football beat reporter, at jspears@tucson.com . On X(Twitter): @JustinESports Respond: Write a letter to the editor | Write a guest opinion Subscribe to stay connected to Tucson. A subscription helps you access more of the local stories that keep you connected to the community. Be the first to know Get local news delivered to your inbox! Sports Reporter